glp 1 drugs and cholesterol Do GLP-1 Help With High Cholesterol? Evidence Guidance Glucagon-Like Peptide-1: New Regulator in
Description
Although body mass index data were not available for this cohort, our findings suggest that any unmeasured obesity is likely to have been more prevalent in the GLP1 receptor agonist group, with any associated bias potentially moving the estimate towards increased risk of thyroid cancer
Funding Open access funding provided by Centre Hospitalier Universitaire de Lille
The percentage of participants who discontinued the medication due to AE ranged between 20 and 29%
doi: 10.1056/NEJMoa2206038 119 AdriaenssensAEBiggsEKDarwishTTadrossJSukthankarTGirishMet al
[DOI] [PubMed] [Google Scholar] 42.Siddeeque N., Hussein M.H., Abdelmaksoud A., Bishop J., Attia A.S., Elshazli R.M., Fawzy M.S., Toraih E.A
